Scientists scan brains of cocaine users to uncover dopamine secrets
NCT ID NCT05011760
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study uses brain scans (PET) to measure how much dopamine is released after a low dose of amphetamine in people with cocaine use disorder. Researchers want to understand brain changes linked to addiction. About 30 adults aged 18-55 with cocaine use disorder will participate. No treatment is tested; the goal is to learn more about the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCAINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of PIttsburgh
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Weight-Loss drug may curb stimulant cravings, brain scans suggest
- Brain scans reveal how stress fuels cocaine relapse
- Sound waves against addiction: ultrasound zaps cocaine cravings
- Magic mushroom compound tested to help people quit cocaine
- New drug tested against cocaine: no cure, just safety check
- Sleep trackers reveal cocaine Withdrawal's hidden toll